Sean P. David, M.D., D.Phil.
Publication Details
-
Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study.
Nicotine Tob Res. 2013; (2): 518-26
There is increasing evidence that response to pharmacological treatment for nicotine dependence may be moderated by genetic polymorphisms. However, the feasibility, acceptability, and impact of genetically tailoring treatment in real-world clinical settings are unknown.
Help